Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1973 Oct 20;4(5885):127–131. doi: 10.1136/bmj.4.5885.127

Antigenic Variants of Influenza B Virus

G C Schild, Marguerite S Pereira, Pratima Chakraverty, Marion T Coleman, W R Dowdle, W K Chang
PMCID: PMC1587127  PMID: 4201694

Abstract

From 1967 to 1971 little antigenic variation was detected in the prevalent influenza B viruses but in December 1972 a new antigenic variant of influenza B was isolated in Hong Kong from sporadic cases of influenza. The new variant, B/Hong Kong/5/72, possessed a haemagglutinin antigen which showed considerable antigenic differences from that of former influenza B strains while its neuraminidase antigen was closely related to that of the earlier, 1967-71, isolates. The B/Hong Kong/5/72 variant became the predominant influenza B strain in the United Kingdom by early summer 1973, and in both the United Kingdom and Japan this strain was associated with outbreaks of influenza. Strains antigenically intermediate between the 1967-71 isolates and B/Hong Kong/5/72 were isolated in a number of countries, often concurrently with B/Hong Kong/5/72-like strains.

Serological studies indicated that antibody to B/Hong Kong/5/72 was infrequent in the populations in the United Kingdom and the U.S.A., suggesting the possibility of future epidemic activity associated with the new variant. In addition, conventional inactivated influenza vaccines containing the older influenza B isolates given to volunteers stimulated poor antibody responses to B/Hong Kong/5/72 virus. These studies indicate the desirability of immunizing high risk patients against B/Hong Kong/5/72-like viruses before the coming influenza season. Vaccine containing the new variant influenza B strain are currently available in the United Kingdom.

Full text

PDF
127

Images in this article

128FIG. 1
on p.128

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aymard-Henry M., Coleman M. T., Dowdle W. R., Laver W. G., Schild G. C., Webster R. G. Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ. 1973;48(2):199–202. [PMC free article] [PubMed] [Google Scholar]
  2. Brand C. M., Skehel J. J. Crystalline antigen from the influenza virus envelope. Nat New Biol. 1972 Aug 2;238(83):145–147. doi: 10.1038/newbio238145a0. [DOI] [PubMed] [Google Scholar]
  3. Chakraverty P. Antigenic relationship between influenza B viruses. Bull World Health Organ. 1971;45(6):755–766. [PMC free article] [PubMed] [Google Scholar]
  4. Chakraverty P. Antigenic relationships between the neuraminidases of influenza B virus. Bull World Health Organ. 1972;46(4):473–476. [PMC free article] [PubMed] [Google Scholar]
  5. HENNESSY A. V., MINUSE E., DAVENPORT F. M. A TWENTY-ONE-YEAR EXPERIENCE WITH ANTIGENIC VARIATION AMONG INFLUENZA B VIRUSES. J Immunol. 1965 Feb;94:301–306. [PubMed] [Google Scholar]
  6. LAVER W. G. STRUCTURAL STUDIES ON THE PROTEIN SUBUNITS FROM THREE STRAINS OF INFLUENZA VIRUS. J Mol Biol. 1964 Jul;9:109–124. doi: 10.1016/s0022-2836(64)80094-2. [DOI] [PubMed] [Google Scholar]
  7. Schild G. C. Evidence for a new type-specific structural antigen of the influenza virus particle. J Gen Virol. 1972 Apr;15(1):99–103. doi: 10.1099/0022-1317-15-1-99. [DOI] [PubMed] [Google Scholar]
  8. Schild G. C. Studies with antibody to the purified haemagglutinin of an influenza Ao virus. J Gen Virol. 1970 Dec;9(3):191–200. doi: 10.1099/0022-1317-9-3-191. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES